Aegerion Pharmaceuticals Inc. (AEGR): Broadfin Capital Raises Its Stake Ahead of Merger

Page 10 of 10

Page 10 of 10 – SEC Filing
Exhibit B
TRANSACTIONS IN THE ISSUER BY THE REPORTING PERSONS
DURING THE PAST SIXTY DAYS
DATE
SECURITY
TRANSACTION
AMOUNT
PRICE
09/09/2016
Common Stock, $0.001 par value
Purchase
100,000
$1.595
09/12/2016
Common Stock, $0.001 par value
Purchase
100,000
$1.696
09/12/2016
Common Stock, $0.001 par value
Purchase
76,000
$1.7

Follow Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR)

Page 10 of 10